Clin Infect Dis: 人类免疫缺陷病毒感染的孕妇会导致肠屏障功能障碍和微生物易位且会造成早产

2018-09-15 MedSci MedSci原创

有文献报道,人类免疫缺陷病毒(HIV)感染人群即使在积极治疗时也会有较高的早产率(PTB)。尽管如此,只有艾滋病毒感染而没有发病的孕妇中有一部分也会出现PTB,这表明艾滋病毒感染本身以外的风险因素在导致孕妇流产中也很重要。炎症是未感染人群中已知的导致流产的危险因素,但尚未有研究报道其在HIV感染人群中的作用;本项研究的的目标是确定HIV感染孕妇的炎症与PTB的之间的关联。

背景
有文献报道,人类免疫缺陷病毒(HIV)感染人群即使在积极治疗时也会有较高的早产率(PTB)。尽管如此,只有艾滋病毒感染而没有发病的孕妇中有一部分也会出现PTB,这表明艾滋病毒感染本身以外的风险因素在导致孕妇流产中也很重要。炎症是未感染人群中已知的导致流产的危险因素,但尚未有研究报道其在HIV感染人群中的作用;本项研究的的目标是确定HIV感染孕妇的炎症与PTB的之间的关联。

方法
在一项接受nevirapine治疗的HIV感染的孕妇的随机试验中,研究人员对其中107名患者进行了病例对照研究(26例实验组,81名对照组),以确定母体炎症与PTB的关系。入组标准为PTB(<37周孕龄)。研究人员通过测量一般炎症标志物(C-反应蛋白[CRP]),肠屏障功能障碍(肠道脂肪酸结合蛋白[I-FABP])和微生物易位/单核细胞活化(可溶性CD14 [sCD14])的血浆水平来评估孕妇体内炎症。多变量逻辑回归用于确定每个标记物与PTB之间的关系。

结果
在多变量模型中,CD14的增加与PTB的发生概率成正相关关系([aOR],2.45; 95%[CI],1.24-4.86),CD163(aOR,3.87; 95%[CI],1.43-10.49)和I-FABP(aOR,2.28; 95%CI,1.18-4.41)也与PTB的发生存在相关性, 但CRP的水平与PTB的发生无显着关系(aOR,0.72; 95%CI,0.48-1.09)。

结论
本项研究结果表明,选择的免疫标记可以识别HIV-1感染人群中PTB风险较高的女性,由HIV感染导致的调节肠屏障障碍和微生物易位可能会影响PTB的发生。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=2027269, encodeId=2487202e269c6, content=<a href='/topic/show?id=75575069e90' target=_blank style='color:#2F92EE;'>#微生物易位#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50697, encryptionId=75575069e90, topicName=微生物易位)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Thu Mar 28 21:38:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824967, encodeId=730c182496eda, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Wed Jun 05 07:38:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022461, encodeId=7b782022461bc, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Feb 02 21:38:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735713, encodeId=0e6c1e35713df, content=<a href='/topic/show?id=634d250460b' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25046, encryptionId=634d250460b, topicName=人类免疫缺陷病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9b33951518, createdName=szhvet, createdTime=Mon Apr 08 02:38:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012797, encodeId=c7fc2012e977b, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Jul 31 22:38:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651679, encodeId=570316516e938, content=<a href='/topic/show?id=26c125044e5' target=_blank style='color:#2F92EE;'>#人类免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25044, encryptionId=26c125044e5, topicName=人类免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091524239599, createdName=FukaiBao, createdTime=Thu Nov 15 19:38:00 CST 2018, time=2018-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992325, encodeId=383519923251f, content=<a href='/topic/show?id=71df2914104' target=_blank style='color:#2F92EE;'>#免疫缺陷病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29141, encryptionId=71df2914104, topicName=免疫缺陷病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Apr 07 19:38:00 CST 2019, time=2019-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421189, encodeId=c0141421189b0, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488982, encodeId=145c148898230, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Sep 17 11:38:00 CST 2018, time=2018-09-17, status=1, ipAttribution=)]

相关资讯

IBD:术后IL-6能预测克罗恩病患者选择性手术后早期腹腔感染的发生

白细胞介素-6(IL-6)在预测克罗恩病(CD)患者腹腔内脓毒症并发症(IASCs)中的作用目前仍不清楚。本项研究评估了CD患者的血清IL-6时程及其与术后IASCs的相关性。

Nitric oxide induces HIF-1alpha stabilization and expression of intestinal trefo

Riano, A., D. Ortiz-Masia, et al. (2011). "Nitric oxide induces HIF-1alpha stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing." J Gastroen

J Gastroenterology: 克罗恩病患者中肠源干细胞的修饰与疾病活动存在相互影响

肠干细胞(ISCs)在维持体内平衡以及受损肠上皮的再生中发挥着不可或缺的作用。然而,克罗恩病(CD)的炎症环境是否会影响常驻小肠干细胞的特性仍然不明确,本项研究通过体外实验阐明了他们之间的关系。